- Report
- January 2026
- 383 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 462 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 369 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 372 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 550 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 266 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 377 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 451 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 382 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 468 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 385 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 564 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 297 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 291 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 104 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 377 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 368 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 384 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 140 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 379 Pages
Global
From €5217EUR$5,850USD£4,523GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more